Clinical trial
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
NCT00633789
Study timeline
Study start (unknown)2008-06-01Date precision: month
Registry last updated2015-10-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Non-small Cell Lung Cancerunresolved
Transitional Cell Carcinomaunresolved
Soft Tissue Sarcomaunresolved
Gastric/Esophageal Adenocarcinomaunresolved
Interventions
Sponsors & collaborators
Bristol-Myers Squibblead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00633789 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.